{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:19:03Z","timestamp":1793683143932,"version":"4.5.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.07.025","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T17:48:09Z","timestamp":1596131289000},"page":"6153-6161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Teng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-013X","authenticated-orcid":false,"given":"Enmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.025_b0005","unstructured":"Lee JY, Wilson MR. A review of pseudorabies (Aujeszky's disease) in pigs. The Canadian veterinary journal = La revue veterinaire canadienne 20; 1979:65\u201369."},{"key":"10.1016\/j.vaccine.2020.07.025_b0010","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1016\/j.vaccine.2015.09.066","article-title":"Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge","volume":"33","author":"Hu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.025_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02058-16","article-title":"Age-dependent differences in pseudorabies virus neuropathogenesis and associated cytokine expression","volume":"91","author":"Verpoest","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.vaccine.2017.01.003","article-title":"Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus","volume":"35","author":"Zhou","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.025_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2016.03.002","article-title":"A live, attenuated pseudorabies virus strain JS-2012 deleted for gE\/gI protects against both classical and emerging strains","volume":"130","author":"Tong","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2020.07.025_b0030","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1128\/jvi.61.12.4030-4032.1987","article-title":"Role of a structural glycoprotein of pseudorabies in virus virulence","volume":"61","author":"Mettenleiter","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0035","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/jvi.62.8.2712-2717.1988","article-title":"Role of glycoprotein gIII of pseudorabies virus in virulence","volume":"62","author":"Mettenleiter","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11262-015-1190-0","article-title":"Molecular epidemiology of outbreak-associated pseudorabies virus (PRV) strains in central China","volume":"50","author":"Wang","year":"2015","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2020.07.025_b0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virol.2015.04.013","article-title":"Genomic characterization of emergent pseudorabies virus in China reveals marked sequence divergence: evidence for the existence of two major genotypes","volume":"483","author":"Ye","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.07.025_b0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/MMBR.69.3.462-500.2005","article-title":"Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine","volume":"69","author":"Pomeranz","year":"2005","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"key":"10.1016\/j.vaccine.2020.07.025_b0055","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1038\/sj.emboj.7600875","article-title":"Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry","volume":"24","author":"Krummenacher","year":"2005","journal-title":"The EMBO journal"},{"key":"10.1016\/j.vaccine.2020.07.025_b0060","article-title":"Structure-function dissection of the Pseudorabies virus glycoprotein B fusion loops","author":"Vallbracht","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/0022-1317-83-2-301","article-title":"Characterization of pseudorabies virus glycoprotein C attachment to heparan sulfate proteoglycans","volume":"83","author":"Rue","year":"2002","journal-title":"J Gener Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006314","article-title":"Structural basis of nectin-1 recognition by pseudorabies virus glycoprotein D","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.07.025_b0075","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/BF01322536","article-title":"Induction of protective antibody responses against pseudorabies virus by intranasal vaccination with glycoprotein B in mice","volume":"140","author":"Takada","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006777","article-title":"Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.07.025_b0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/jvi.64.2.802-812.1990","article-title":"Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes","volume":"64","author":"Zuckermann","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1292\/jvms.59.657","article-title":"Protective effect of glycoprotein gC-rich antigen against pseudorabies virus","volume":"59","author":"Katayama","year":"1997","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2020.07.025_b0095","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1016\/j.vaccine.2015.06.088","article-title":"Immunogenicity and safety of the 9-valent HPV vaccine in men","volume":"33","author":"Castellsague","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.025_b0100","unstructured":"Hodgens A, Marathi R. in StatPearls; 2020."},{"key":"10.1016\/j.vaccine.2020.07.025_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"years of PCV2 vaccines and vaccination: Is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2017.01.001","article-title":"Classical swine fever vaccines-state-of-the-art","volume":"206","author":"Blome","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01614-18","article-title":"Virulent pseudorabies virus infection induces a specific and lethal systemic inflammatory response in mice","volume":"92","author":"Laval","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/1471-2164-10-491","article-title":"Whole-genome analysis of pseudorabies virus gene expression by real-time quantitative RT-PCR assay","volume":"10","author":"Tombacz","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2020.07.025_b0125","first-page":"1006","article-title":"Pseudorabies virus in North-West Italian wild boar (Sus scrofa) populations: prevalence and risk factors to support a territorial risk-based surveillance","volume":"54","author":"Caruso","year":"2018","journal-title":"Veterinaria italiana"},{"key":"10.1016\/j.vaccine.2020.07.025_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12917-018-1347-x","article-title":"Seroprevalence and risk factors associated with Pseudorabies virus infection in Tibetan pigs in Tibet","volume":"14","author":"Wu","year":"2018","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2020.07.025_b0135","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00705-011-1080-2","article-title":"Pseudorabies virus in wild swine: a global perspective","volume":"156","author":"Muller","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prevetmed.2018.12.005","article-title":"An economic assessment of pseudorabies (Aujeszky' disease) elimination on hog farms in China","volume":"163","author":"Liu","year":"2019","journal-title":"Preventive Vet Med"},{"key":"10.1016\/j.vaccine.2020.07.025_b0145","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3201\/eid2406.171612","article-title":"Human endophthalmitis caused by pseudorabies virus infection, China, 2017","volume":"24","author":"Ai","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.025_b0150","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-019-00822-2","article-title":"Human encephalitis caused by pseudorabies virus infection: a case report","author":"Wang","year":"2020","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/22221751.2018.1563459","article-title":"Pseudorabies virus: a neglected zoonotic pathogen in humans?","volume":"8","author":"Wong","year":"2019","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.vaccine.2020.07.025_b0160","article-title":"Human pseudorabies virus infection: a new threat in China","author":"Ou","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.07.025_b0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3201\/eid2001.130531","article-title":"Pathogenic pseudorabies virus, China, 2012","volume":"20","author":"Yu","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.025_b0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2016.01.016","article-title":"Genomic analyses reveal that partial sequence of an earlier pseudorabies virus in China is originated from a Bartha-vaccine-like strain","volume":"491","author":"Ye","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.07.025_b0175","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vetmic.2015.09.021","article-title":"Emergence of a Pseudorabies virus variant with increased virulence to piglets","volume":"181","author":"Tong","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-1135(91)90119-Z","article-title":"Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine","volume":"29","author":"Mukamoto","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.07.025_b0185","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0264-410X(98)00349-1","article-title":"Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D","volume":"17","author":"Haagmans","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.025_b0190","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/jvi.61.12.3977-3982.1987","article-title":"Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells","volume":"61","author":"Marchioli","year":"1987","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:53Z","timestamp":1759401953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20309415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20309415"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}